Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.bbrc.2020.10.012 http://scihub22266oqcxt.onion/10.1016/j.bbrc.2020.10.012 33069360!7547570!33069360     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33069360&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biochem+Biophys+Res+Commun 2021 ; 538 (ä): 192-203 Nephropedia Template TP {{tp|p=33069360|t=2021. Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies |pdf=|usr=}}{{33069360}} gab.com Text Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies JO: Biochem Biophys Res Commun http://www.kidney.de/pget.php?&tw=1&pmid=33069360 #FOAvip Immediately from the outset of the COVID-19 pandemic, researchers from diverse biomedical and biological disciplines have united to study the novel pandemic virus, SARS-CoV-2. The antibody response to SARS-CoV-2 has been a major focus of COVID-19 research due to its clinical relevance and importance in vaccine and therapeutic development. Isolation and characterization of antibodies to SARS-CoV-2 have been accumulating at an unprecedented pace. Most of the SARS-CoV-2 neutralizing antibodies to date target the spike (S) protein receptor binding domain (RBD), which engages the host receptor ACE2 for viral entry. Here we review the binding sites and molecular features of monoclonal antibodies that target the SARS-CoV-2 RBD, including a few that also cross-neutralize SARS-CoV. Twit Text FOAVip Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies ????Biochem Biophys Res Commun http://www.kidney.de/pget.php?&tw=1&pmid=33069360 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33069360 #FOAvip English Wikipedia <ref>{{Cite pmid|33069360}}</ref> Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies #MMPMID33069360 Yuan M; Liu H; Wu NC; Wilson IA Biochem Biophys Res Commun 2021[Jan]; 538 (ä): 192-203 PMID33069360show ga Immediately from the outset of the COVID-19 pandemic, researchers from diverse biomedical and biological disciplines have united to study the novel pandemic virus, SARS-CoV-2. The antibody response to SARS-CoV-2 has been a major focus of COVID-19 research due to its clinical relevance and importance in vaccine and therapeutic development. Isolation and characterization of antibodies to SARS-CoV-2 have been accumulating at an unprecedented pace. Most of the SARS-CoV-2 neutralizing antibodies to date target the spike (S) protein receptor binding domain (RBD), which engages the host receptor ACE2 for viral entry. Here we review the binding sites and molecular features of monoclonal antibodies that target the SARS-CoV-2 RBD, including a few that also cross-neutralize SARS-CoV. |Angiotensin-Converting Enzyme 2/chemistry/*immunology[MESH] |Antibodies, Neutralizing/*immunology[MESH] |Antibodies, Viral/*immunology[MESH] |Binding Sites/immunology[MESH] |Humans[MESH] |Protein Binding/immunology[MESH] |Protein Domains/immunology[MESH] |Receptors, Virus/chemistry/*immunology[MESH] |SARS-CoV-2/*immunology[MESH]Recognition of the SARS-CoV-2 receptor binding domain by neutralizing (epmc).pdf DeepDyve Pubget Overpricing